系统免疫炎症指数对老年射血分数减低型心力衰竭病人下肢深静脉血栓形成的预测价值

doi:10.3969/j.issn.1003-9198.2023.07.012

摘要/Abstract

摘要： 目的评价系统免疫炎症指数(SII)对老年射血分数减低型心力衰竭(HFrEF)病人下肢深静脉血栓形成(LEDVT)的预测价值。方法回顾性分析2020年8月至2022年5月于我院急诊首诊并住院的163例老年HFrEF病人的临床资料。采用单因素和多因素Logistic回归分析筛选HFrEF病人LEDVT发生的独立危险因素,并评价相关因素对LEDVT的预测价值。结果 163例HFrEF病人中,合并LEDVT 32例(19.6%)。与无LEDVT组相比,LEDVT组病人年龄更大,急诊就诊时Autar评分、SII和血浆D-二聚体水平更高(均P＜0.05)。多因素Logistic回归分析表明,SII、血浆D-二聚体为LEDVT的独立预测因子。ROC曲线分析表明,SII预测LEDVT的能力最强,AUC为0.782。据SII截断值(629×10⁹/L)将病人分为SII_高组和SII_低组,Kaplan-Meier生存曲线分析表明,SII_高组LEDVT发生率显著高于SII_低组,差异有统计学意义(χ²=9.133,P=0.003)。结论急诊就诊时SII水平可作为老年HFrEF病人LEDVT的独立预测因子,用其进行危险分层有助于早期识别高危人群。

关键词: 心力衰竭, 系统免疫炎症指数, 下肢深静脉血栓形成, 炎症, 预后

Abstract: Objective To evaluate the predictive value of systemic immune-inflammation index (SII) for lower extremity deep venous thrombosis (LEDVT) in the elderly patients with heart failure with reduced ejection fraction (HFrEF). Methods A retrospective study was performed, and a total of 163 elderly HFrEF patients in our hospital from August 2020 to May 2022 were enrolled in this study. The independent risk factors of LEDVT were screened by univariate and multivariate Logistic regression analysis, and the predictive value of the variants for the incidence of LEDVT was evaluated by receiver operating characteristic (ROC) curve. Results Thirty-two cases (19.6%) presented with LEDVT. Compared to the non-LEDVT group, the age, the levels of Autar score, SII and plasma D-dimer at admission were significantly higher in the LEDVT group (P<0.05). Multivariate Logistic regression showed that the level of SII, plasma D-dimer were independent influencing factors of LEDVT. ROC curve showed that SII had significant predictive value for LEDVT with an AUC of 0.782, and the cutoff value of SII was 629×10⁹/L. Kaplan-Meier survival curve analysis showed that the incidence rate of LEDVT in high SII group (>629×10⁹/L) was significantly higher than that in low SII group (χ²=9.133, P=0.003). Conclusions SII level at admission can be used as an independent risk predictor of LEDVT in the elderly patients with HFrEF.

Key words: heart failure, systemic immune-inflammatory index, low extremity deep venous thrombosis, inflammation, prognosis

中图分类号:

杨少琦, 杨洋, 邓丽娜, 翟志欣. 系统免疫炎症指数对老年射血分数减低型心力衰竭病人下肢深静脉血栓形成的预测价值[J]. 实用老年医学, 2023, 37(7): 695-699.

YANG Shao-qi, YANG Yang, DENG Li-na, ZHAI Zhi-xin. Predictive value of systemic immune-inflammatory index for lower extremity deep venous thrombosis in elderly patients with heart failure with reduced ejection fraction[J]. Practical Geriatrics, 2023, 37(7): 695-699.

参考文献

[1] DEL BUONO M G, MORONI F, MONTONE R A, et al. Ischemic cardiomyopathy and heart failure after acute myocardial infarction[J]. Curr Cardiol Rep, 2022, 24(10):1505-1515.
[2] FU A Z, FENG X, ASHTON V, et al. Risk factors for recurrent venous thromboembolism: a real-world analysis[J]. Blood Coagul Fibrinolysis, 2022, 33(6):301-309.
[3] MATSUO H, MATSUMURA M, NAKAJIMA Y, et al. Frequency of deep vein thrombosis among hospitalized non-surgical Japanese patients with congestive heart failure[J]. J Cardiol, 2014, 64(6):430-434.
[4] ELBOUDWAREJ O, PATEL J K, LIOU F, et al. Risk of deep vein thrombosis and pulmonary embolism after heart transplantation: clinical outcomes comparing upper extremity deep vein thrombosis and lower extremity deep vein thrombosis[J]. Clin Transplant, 2015, 29(7):629-635.
[5] AUTAR R. Nursing assessment of clients at risk of deep vein thrombosis (DVT): the Autar DVT scale[J]. J Adv Nurs, 1996, 23(4):763-770.
[6] AUTAR R. Calculating patients' risk of deep vein thrombosis[J]. Br J Nurs, 1998, 7(1):7-12.
[7] SPYROPOULOS A C, ANDERSON F A, FITZGERALD G, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE[J]. Chest, 2011, 140(3):706-714.
[8] ALEXANDER M, BURBURY K. A systematic review of biomarkers for the prediction of thromboembolism in lung cancer-results, practical issues and proposed strategies for future risk prediction models[J]. Thromb Res, 2016, 148:63-69.
[9] BORGEL D, BIANCHINI E, LASNE D, et al. Inflammation in deep vein thrombosis: a therapeutic target? [J]. Hematology, 2019, 24(1):742-750.
[10] HU B, YANG X R, XU Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23):6212-6222.
[11] FEST J, RUITER R, IKRAM M A, et al. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study[J]. Sci Rep, 2018, 8(1):10566.
[12] CHEN L, YAN Y, ZHU L, et al. Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy[J]. Cancer Manag Res, 2017, 9:849-867.
[13] TONG Y S, TAN J, ZHOU X L, et al. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer[J]. J Transl Med, 2017, 15(1):221.
[14] AZIZ M H, SIDERAS K, AZIZ N A, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study[J]. Ann Surg, 2019, 270(1):139-146.
[15] SUN Y, LI W, LI A J, et al. Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients[J]. Cancer Manag Res, 2019,11:3153-3162.
[16] HEIDENREICH P A, BOZKURT B, AGUILAR D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2022, 79(17):1757-1780.
[17] MASCIE-TAYLOR C G, GOTO R. Human variation and body mass index: a review of the universality of BMI cut-offs, gender and urban-rural differences, and secular changes[J]. J Physiol Anthropol, 2007, 26(2):109-112.
[18] GUO T M, CHENG B, KE L, et al. Prognostic value of neutrophil to lymphocyte ratio for in-hospital mortality in elderly patients with acute myocardial infarction[J]. Curr Med Sci, 2018, 38(2):354-359.
[19] 陈晓洁, 汪永坚, 俞菁菁, 等. Autar量表在预防乳腺癌术后并发下肢深静脉血栓形成应用的效果观察[J]. 中国护理研究, 2016, 7(30): 2414-2415.
[20] GOK M, KURTUL A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index[J]. Scand Cardiovasc J, 2021, 55(2):91-96.
[21] 叶晓云, 何显森, 方仙, 等. 中性粒细胞与淋巴细胞比值对非瓣膜性心房颤动患者左心房血栓形成的预测价值[J]. 心脑血管病防治, 2019, 19(1):67-70.
[22] XUE J, MA D, JIANG J, et al. Diagnostic and prognostic value of immune/inflammation biomarkers for venous thromboembolism: is it reliable for clinical practice?[J]. J Inflamm Res, 2021, 14:5059-5077.